Chief Executive Officer, Babylon BioConsulting LLC
Dr. Sam Al-Murrani, CEO, Babylon BioConsulting LLC, a human and animal health-based consultancy firm specializing in pre-revenue and early stage valuations of Animal Health and Biotech companies and providing clients with investor outreach, due diligence, business development and intangible asset management and valuation services. He is also Managing Director for Bimini LLC, a privately owned manufacturer of pet dose-form health supplements and health treats.
He is a recognized expert in his field. A summary of his professional experience can be found on his Linkedin page.
Dr. Al-Murrani has a B.Sc. in Animal Science from the University of Edinburgh and a Ph.D. in Immunology/Biochemistry from the Roslin Institute and the Department of Veterinary Pathology at the University of Edinburgh. He holds an M.B.A. in Finance from Baker University.
Acting Executive Director, Missouri Technology Corporation
State of Missouri
The Missouri Technology Corporation (MTC) is a public-private partnership created by the Missouri General Assembly to promote entrepreneurship and foster the growth of new and emerging high-tech companies. MTC focuses on 21st Century bioscience industries that build on Missouri’s rich history in agriculture.
Partner, Hovey Williams LLP
Crissa is a Patent Attorney and Partner at Hovey Williams LLP. She represents large, medium, and small clients across the U.S., as well as several internationally-based corporations and institutions. Her practice focuses primarily on patent preparation, prosecution, enforcement, and licensing in the animal health, life science, chemical, pharmaceutical, medical, mechanical, and food science arts. She also helps companies, institutions, and universities manage and evaluate their IP portfolios and those of their competitors, including the preparation of non-infringement and invalidity opinions, as well as various agreements (e.g., non-compete, non-disclosure, material transfer, etc.). She also handles due diligence, trademark, and trade secret matters. Crissa is also an Adjunct Professor at The University of Kansas School of Law.
Owner, Bleecker Street Consulting
Jane is a veterinarian and animal health pharmaceutical industry professional with 30+ years experience working with multinational and small companies in the USA, Asia, Australia and New Zealand. She is the author of more than 35 publications in peer reviewed journals and has an established track record in global pharmaceutical product development, departmental restructuring/relocation and staff management, Asian R&D unit start up operations, outsourcing and business development.
Jane practiced as a companion animal veterinarian in Australia and the UK for several years before joining Merck Animal Health in 1985 working in positions of increasing responsibility first in Australia and later in the USA. In 1999 she moved to Pfizer Animal Health as Senior Director in Clinical Development later transferring to New Products Marketing and then to a special assignment starting up a pharmaceutical laboratory department in Mumbai, India. In 2006 she joined Argenta Manufacturing, an animal health CMO based in New Zealand, managing their R&D, Project Management and Business Development functions. Today she concurrently serves as the owner of Bleecker Street Consulting specializing in animal health product development services and as Vice President of Clinical and Regulatory Affairs at Nexvet. Jane is also a member of the board of directors at Zomedica.
Her major career achievements include development of multiple pharmaceutical products for the global market, including 5 new chemical entities, taken from pre-clinical through to final regulatory approval and commercialization.
Vice President, Brakke Consulting, Inc.
John is experienced in worldwide product introductions, sales management, market research, financial and business planning, and providing business valuations. At Brakke Consulting, John concentrates his activities on business analysis, transactions, and recruiting assignments. His financial background makes him the go-to person for evaluations of businesses and technologies that are either looking for a new owner or seeking to enter the market. He provides a quantitative slant on major strategic decisions. John also specializes in recruiting assignments for positions that are particularly difficult to fill. Previous to joining Brakke Consulting, Mr. Mannhaupt held several sales, product management, and marketing positions with Sandoz Corporation, a major pharmaceutical, chemical, and agricultural products firm that is now part of Novartis. John also held corporate financial positions with Occidental Petroleum and General Foods, which is now Kraft. He holds an MBA from the Tepper School of Business at Carnegie-Mellon University and a B.S. in Mathematics from Iona College.
Managing Director, Aix Bio Consulting LLC
Robert is managing director of Aix Bio Consulting, a newly created animal health vaccine and bio-therapeutics dedicated consulting company. Aix Bio Consulting works with a diverse network of specialized talent around the globe to support university research groups, start-up companies and large multi-national firms to address challenges, lead finding, market assessment, I.P. support and development strategies.
He has over 32 years of international animal health experience, resulting in the direct or indirect registration of over 80 unique vaccines worldwide. Prior to Aix Bio Consulting, Robert was with Merial for 17 years holding a variety of leadership roles.
Robert has a Master of Science in Veterinary Parasitology and a Doctor of Philosophy, Veterinary Immunology from Texas A&M.
Founding Partner, Cultivian Sandbox Food and Ag Funds I & II
Ron is a founding partner of the Cultivian Sandbox Food and Ag Funds I and II. Ron has over 30 years of experience in bringing new technologies and products to market. He has led research and development for major corporations in agricultural chemicals, field crop and vegetable genetics and breeding, animal health, novel foods and industrial materials. His successful projects include the world’s first field trial of a genetically engineered crop trait in 1986, development and launch of one of the first insect and herbicide resistant corn hybrids in 1996, introduction of a trans-fat free canola oil, and development of dozens of new varieties of field and vegetable crops on three continents. Ron has been a frequent speaker at conferences, a consultant to Federal policy on biotechnology regulatory issues, and active in industry trade groups. Prior to forming Cultivian Ron led the expansion of the biotechnology research and development program of Dow AgroSciences, and founded a biopharmaceutical company, Immuneworks, Inc. Ron currently serves on the boards of directors of Agrivida, AbCelex, Asilomar Bio, enEvolv, Vestaron, Virgin Plants and Rivertop Renewables. He was also a member of the board of directors of Allylix, Aratana, Proterro and Divergence, Inc. Allylix was sold to Evolva, Divergence was sold to Monsanto Company and Aratana was taken public in 2013. Ron holds a Ph.D. from the University of California, Berkeley in plant cell biology, and a bachelor’s degree from the University of Wisconsin, Milwaukee in plant physiology.
Managing Director, Sandbox Industries
Dan Phillips is a Managing Director of Sandbox Industries, where he helps manage the firm's healthcare funds and food & agriculture fund (Cultivian Sandbox). He also helped to build Healthbox, an accelerator program that supports innovative, seed stage healthcare startups. Before joining Sandbox, Dan spent several years in healthcare consulting, most recently as a senior consultant with The Camden Group, where he specialized in hospital strategic planning and service line development.
He also spent a few years with Sg2, a healthcare consulting and thought leadership firm, where he worked with health systems in the UK, Canada, and Southeast Asia. Dan earned his Bachelor of Science degree at the University of Michigan, where he majored in biology.
CEO, Animalytix, LLC
Animalytix® LLC is the animal health industry’s leading provider of geo-located market intelligence. Animalytix sources its sales data from the leading animal health distributors, veterinarians and retailers and maintains a comprehensive database of more than $50 billion in sales history on 15,000+ products from more than 500 manufacturers. Each month, Animalytix publishes a series of syndicated and customized market surveys covering more than 30 unique animal health market segments and provides additional analytical support through a team of Senior Business Advisors, each former operators from the animal health manufacturing or distribution industries.
CEO, BioPharmaPotentials (BPP)
Kansas City, Missouri
Dr. Edward Robb is CEO of BioPharmaPotentials (BPP) an animal health based consultancy that enables its global partners in achieving their extreme potential including technology evaluation, due diligence and assessments of new and repurposed chemical and biologic entities. Services include the execution/conduct of critical Proof of Concept and Proof of Value studies to define value and to provide various opportunity runways. In addition BPP executes clinical efficacy and safety studies in laboratory, target animal and in the clinical setting. BPP develops regulatory and development strategies for small molecules (pharmaceuticals), biologicals (vaccines), medical devises and nutraceuticals. The practice engages on behalf of its clients various public and private funding sources and in the development of manufacturing and quality programs (analytical/formulation development) in concert with the project management to support the technology/product plan. Dr. Robb serves on the Boards of various start-up organizations predominantly in the role as Chief Scientific Officer.
Dr. Robb has a BS in Animal Science, DVM from Cornell University and a Masters in Epidemiology from the University of Pennsylvania; he is a Diplomate of the American College of Veterinary Clinical Nutrition. Dr. Robb has five years of clinical practice and has held various senior leadership positions in Research and Development, Product Development and Business Development at Upjohn, Pharmacia, Pfizer, Embrex, Boehringer Ingelheim Vetmedica, CEVA and Parnell (see Linkedin profile). Dr. Robb’s strong track record for delivering value thru innovation and legacy of leading organizations that achieved game changing registrations and successful commercialization’s spans across specie lines, therapeutic areas, technology platforms and geographies.
Executive Director, Merial Ltd. Atlanta, Georgia
Don Schwartz joined Merck & Co., Inc. as a manager of global marketing communications, rising to his current role as an executive director of Merial’s US Business Operations with responsibilities for business development, market research, regulatory, customer care, veterinary technical solutions, public affairs and business analytical functions. In between, he gained extensive experience in marketing, A&P, product management, finance, manufacturing, media management, packaging development, trademark development and distribution among other business skills. Don was instrumental in the launch of several of his company’s landmark products including IVOMEC, HEARTGARD and FRONTLINE PLUS. He recently led the development of the OraVet line of oral care products.
Don has been the head of a successful advertising and communications agency specializing in pharmaceutical and technical products. He has several books to his credit, including Genus Bos: Cattle Breeds of the World, the standard reference on the subject.
He earned an undergraduate degree in biology from Union College in Schenectady, New York, did graduate work in biology at NYU and has an MS in management from CUNY. Under duress, he will also admit he went to law school.
Partner, Stinson Leonard Street LLP
Andrea is a registered patent attorney with an emphasis in the chemical, biosciences, and animal health fields. She has significant experience in patent prosecution, infringement counseling, and licensing regarding biochemical, chemical, and mechanical inventions. She also has completed extensive reviews and infringement analyses of patents directed to the pharmaceutical, agricultural chemistry, and biochemistry fields. Andrea has developed particular experience in negotiating and drafting intellectual property agreements, including complex technology development and license agreements covering a wide range of technologies.
President & CEO, Shuler Consulting Services
Shuler Consulting Services is focused on working with companies in the area of innovation, planning and execution. SCS has more than 30 years of experience in creating and building successful businesses and developing a strong market position for their products and services. Rich Shuler has worked with businesses, producer organizations, churches and universities to develop long range strategic plans and organizational structure. SCS also assists businesses in acquiring products and technologies that fit the company’s strategic focus.
President, AgTech Advisors, LLC
Tony Simpson is a co-founder and partner in Fulcrum Global Capital, a venture capital fund focused on investing in agriculture, animal health and health IT. Tony’s career spans more than 24 years in trading, operations, corporate leadership and investing. He was a Managing Director for the Kansas Bioscience Authority (KBA) from 2009 through July 0f 2015 where he led the organization’s investment efforts in agtech, animal health and bioenergy. He led KBA’s investments in companies such as Aratana Therapeutics, Green Dot, SmartVet, and Advanced Animal Diagnostics.
Before joining the KBA, Tony spent 11 years in the fuel ethanol industry. He was a General Manager with Broin Management (now POET Biorefining), where he led the business start-up of two major green-field ethanol plants in Albert Lea, Minnesota and Caro, Michigan. Later, he led ED&F Man’s U.S. ethanol division, where he was responsible for both business development and operations management of facilities in Caldwell, Idaho and Kingston, Jamaica. Tony started his career as a grain merchandiser with ADM, and was later the General Manager of ADM Milling Company’s Minneapolis “A” mill.
Tony serves as a Principal Advisor to the Larta Institute, where he mentors early-stage agtech and animal health companies on the development and execution of their commercialization strategies. He also serves on the board of directors of Green Dot Holdings, Advanced Animal Diagnostics, and SmartVet.
Tony holds an Economics Degree from Millikin University, an MBA from the Carlson School of Business at the University of Minnesota-Minneapolis, and completed the Private Equity and Venture Capital Executive Education Program at Harvard Business School.